In the present study, the impact of supplementation with this specific combination of metabolic cofactors was evaluated for the first time, focusing on the main features of NAFLD/NASH, liver steatosis, hepatic inflammation and hepatic insulin resistance. This evidence concerns the gene INS and fatty liver disease.